Join us for an engaging episode featuring Rachel Reboulet, Founder and Biotech Ops Partner at Streamline BioOps, as we explore the dynamic and fast-evolving world of life science startups. With extensive experience guiding companies from Seed through Series B, Rachel offers a rare inside look at what it takes to build resilient operations that support scientific ambition and long-term growth.

In this conversation, we uncover how she partners with emerging biotech teams to establish strong operational frameworks, balance scientific priorities with business needs, and create the structures necessary for sustainable scale. Rachel walks us through the realities of early-stage development—from assembling the right team and navigating resource constraints to implementing processes that can evolve alongside the science.

We also discuss the challenges startups face during critical growth phases, including managing cross-functional complexity, preparing for fundraising milestones, and maintaining strategic clarity in rapidly shifting environments. Her journey highlights why operational excellence is not just supportive but foundational to successful biotech innovation.

Episode Highlights:
A deep dive into the core requirements of early-stage biotech success
Insights into designing and scaling operational systems built for growth
Real examples of overcoming Seed-to-Series B hurdles with strategic execution

Whether you’re a founder shaping your first company, an operator refining your systems, or a biotech professional learning the intricacies of building in this sector, this episode delivers practical guidance and strategic perspective. Get ready to understand how operational strategy fuels scientific progress—and why the strongest biotech companies are built on both innovation and disciplined execution.